Sai Life Sciences Ltd approves Q2 FY27 results, reporting consolidated revenue of ₹658.6 crore and net profit of ₹98.3 crore
- Revenue rose 22.5% year on year and 18.8% sequentially; net profit increased 17.3% year on year and 34.0% sequentially.
- Estimated EBITDA margin was 28.3%; no exceptional item was recorded in Q2.
- Auditors issued an unmodified limited-review conclusion; the Board also appointed three senior management personnel and allotted 1,08,005 shares under employee stock-option plans.
